WHO Pandemic Agreement: Progress on Pathogen Access and Benefit sharing (PABS) System
The global effort to fortify defenses against future pandemics took a meaningful step forward this November as World Health Association (WHO) Member States initiated the first formal discussions surrounding the draft text of the annex to the WHO Pandemic Agreement. this annex focuses on establishing a robust Pathogen Access and Benefit Sharing (PABS) system – a cornerstone of the agreement adopted earlier in 2025, designed to enhance global pandemic preparedness and response.
The pivotal discussions unfolded during the Third meeting of the Intergovernmental Working Group (IGWG), held from November 3rd to 7th in Geneva. established by the World Health Assembly, the IGWG is tasked with drafting and negotiating this crucial PABS annex, prioritizing a framework for international collaboration in the face of emerging infectious disease threats.
The Imperative of Rapid Pathogen Sharing
A central tenet of effective pandemic response is the swift identification and sharing of pathogens with pandemic potential. This necessitates the rapid dissemination of genetic details and biological materials to empower scientists in the development of critical tools - diagnostics, therapeutics, and vaccines. The PABS system aims to streamline this process, facilitating timely access while together ensuring equitable benefit-sharing arising from the utilization of these resources.
The system isn’t simply about access; it’s about fairness. It seeks to establish a framework where the benefits derived from pathogen materials and sequence information are distributed equitably amongst contributing nations and stakeholders. This addresses a critical gap in previous pandemic responses, where access to life-saving technologies was frequently enough unevenly distributed, exacerbating health inequities.
Operationalizing Equitable Access: Article 12 and Beyond
The draft text currently under consideration directly addresses the commitments outlined in Article 12 of the WHO Pandemic Agreement, specifically focusing on equitable access to life-saving countermeasures during health emergencies. This includes provisions designed to accelerate the development and distribution of vaccines, treatments, and diagnostics to all nations, regardless of economic status.
“Difficult decisions on making the world safer from the threat of future pandemics require difficult conversations,” noted Ambassador Tovar da Silva Nunes, co-chair of the IGWG Bureau, representing Brazil.”This week, WHO Member States have shown they are capable of those. By considering complex issues head-on, these negotiations are ensuring that future pandemic responses will be fair, timely and grounded in solidarity.”
Mr.Matthew Harpur, the other IGWG Bureau co-chair from the United Kingdom, echoed this sentiment, emphasizing the collective commitment demonstrated by nations worldwide.”Countries across the world this week again showed their commitment to making sure we, collectively, are better protected from future pandemics by constructively engaging on making progress in these negotiations and we look forward to further discussions in December.”
Stakeholder Engagement and the Path Forward
Recognizing the importance of a multi-faceted approach, the IGWG also engaged with key stakeholders, including representatives from civil society organizations and the pharmaceutical industry, to gather diverse perspectives on the PABS annex. This inclusive process aims to ensure the final document reflects a broad consensus and addresses the concerns of all parties involved.
the finalized PABS annex is slated for submission to the Seventy-ninth World Health Assembly in May 2026. Following adoption by the Assembly,the agreement will then undergo the process of national parliamentary approval in each member state,solidifying its legal standing and paving the way for implementation.
WHO Director-General dr.Tedros Adhanom Ghebreyesus underscored the significance of this collaborative effort. “I thank Member States for their vital efforts to negotiate the first draft of the PABS annex and commend them on the progress made in finding shared positions and solutions to the shared risks and challenges posed by future pandemics,” he stated. “Solidarity is our best immunity. Finalizing the Pandemic Agreement, through a commitment to multilateral action, is our collective promise to protect humanity.”
Evergreen Section: The Evolution of pandemic Preparedness
The development of the WHO Pandemic Agreement and its PABS system represents a paradigm shift in global health security. Historically, pandemic responses were frequently enough characterized by fragmented efforts, nationalistic approaches, and inequitable access to resources. The lessons learned from recent pandemics – including the stark disparities in vaccine distribution during the COVID-19 crisis – highlighted the urgent need for a more coordinated, equitable, and proactive framework.
This agreement builds upon decades of work in international health regulations and represents a commitment to strengthening global health architecture. The PABS system, in particular, addresses a long-standing challenge: incentivizing the sharing of pathogen information while ensuring that the benefits derived from that information are distributed fairly. This is not merely a matter of altruism; it’s a matter of self-interest. A more equitable and collaborative approach to pandemic preparedness ultimately protects all nations from the devastating consequences of future outbreaks.The success of this agreement will depend
Keep reading